James Halliwell joined C+D as editor-in-chief in February 2024. A business journalist for the last 15 years, he’s looking forward to developing the bond between C+D and its readers and bringing them more of what they want to read, in the evolving ways they want to read it.
Latest from James Halliwell
As community pharmacy hotly debates whether weight-loss jabs are regulated closely enough, does weight-loss wonder Novo Nordisk have bigger things to worry about?
What if the government has been working on a package of pharmacy contract reforms that would give the industry the structured and reassuring lift it deserves?
In part two of C+D's Review of the Year, we look back at 12 months of trade associations, politics, and what's happening in pharmacy around the world...
After a topsy turvy year we look back at the last 12 months in community pharmacy, with part one featuring funding, services, shortages and weight-loss jabs...
We want to hear the important things you have to say about life in pharmacy today...